These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32499118)

  • 21. Consumer perceptions of 'legal' and 'illegal' cannabis in US states with legal cannabis sales.
    Fataar F; Goodman S; Wadsworth E; Hammond D
    Addict Behav; 2021 Jan; 112():106563. PubMed ID: 32768793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perceptions and acceptability of pictorial health warning labels vs text only--a cross-sectional study in Lao PDR.
    Sychareun V; Hansana V; Phengsavanh A; Chaleunvong K; Tomson T
    BMC Public Health; 2015 Oct; 15():1094. PubMed ID: 26510415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18).
    Lintzeris N; Mills L; Suraev A; Bravo M; Arkell T; Arnold JC; Benson MJ; McGregor IS
    Harm Reduct J; 2020 Jun; 17(1):37. PubMed ID: 32513180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-reported Impact of the COVID-19 Pandemic on Cannabis Use in Canada and the United States.
    Wadsworth E; Goodman S; Hammond D
    J Psychoactive Drugs; 2023; 55(4):483-492. PubMed ID: 35981105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of theory-driven graphic warning labels in motivation to quit: a qualitative study on perceptions from low-income, urban smokers.
    Mead EL; Cohen JE; Kennedy CE; Gallo J; Latkin CA
    BMC Public Health; 2015 Feb; 15():92. PubMed ID: 25880277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examining Interpretations of Graphic Cigarette Warning Labels Among U.S. Youth and Adults.
    McQueen A; Waters EA; Kaphingst KA; Caburnay CA; Sanders Thompson VL; Boyum S; Kreuter MW
    J Health Commun; 2016 Aug; 21(8):855-67. PubMed ID: 27410753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of plain packaging and health warnings on consumer appeal of cannabis products.
    Goodman S; Leos-Toro C; Hammond D
    Drug Alcohol Depend; 2019 Dec; 205():107633. PubMed ID: 31678837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.
    Goodman S; Wadsworth E; Leos-Toro C; Hammond D;
    Int J Drug Policy; 2020 Feb; 76():102658. PubMed ID: 31927413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does perception of drug-related harm change with age? A cross-sectional online survey of young and older people.
    Cheeta S; Halil A; Kenny M; Sheehan E; Zamyadi R; Williams AL; Webb L
    BMJ Open; 2018 Nov; 8(11):e021109. PubMed ID: 30401725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis health knowledge and risk perceptions among Canadian youth and young adults.
    Leos-Toro C; Fong GT; Meyer SB; Hammond D
    Harm Reduct J; 2020 Aug; 17(1):54. PubMed ID: 32746859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis use patterns at the dawn of US cannabis reform.
    Kumar N; Puljević C; Ferris J; Winstock A; Barratt MJ
    J Cannabis Res; 2019 Jun; 1(1):5. PubMed ID: 33526080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does Adding Information on Toxic Constituents to Cigarette Pack Warnings Increase Smokers' Perceptions About the Health Risks of Smoking? A Longitudinal Study in Australia, Canada, Mexico, and the United States.
    Cho YJ; Thrasher JF; Swayampakala K; Lipkus I; Hammond D; Cummings KM; Borland R; Yong HH; Hardin JW
    Health Educ Behav; 2018 Feb; 45(1):32-42. PubMed ID: 28715260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impacts of potency, warning messages, and price on preferences for Cannabis flower products.
    Shi Y; Cao Y; Shang C; Pacula RL
    Int J Drug Policy; 2019 Dec; 74():1-10. PubMed ID: 31382201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Keeping up with the times: how national public health and governmental organizations communicate about cannabis on Twitter.
    van Draanen J; Krishna T; Tsang C; Liu S
    Subst Abuse Treat Prev Policy; 2019 Sep; 14(1):38. PubMed ID: 31511026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact and acceptability of Canadian-style cigarette warning labels among U.S. smokers and nonsmokers.
    Peters E; Romer D; Slovic P; Jamieson KH; Wharfield L; Mertz CK; Carpenter SM
    Nicotine Tob Res; 2007 Apr; 9(4):473-81. PubMed ID: 17454702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perceived support for medical cannabis use among approved medical cannabis users in Canada.
    Leos-Toro C; Shiplo S; Hammond D
    Drug Alcohol Rev; 2018 Jul; 37(5):627-636. PubMed ID: 29873132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of cannabis use and alcohol-associated adverse effects in a representative sample of U.S. adolescents and youth (2002-2014) a cross-sectional study.
    Ramadan MM; Banta JE; Bahjri K; Montgomery SB
    J Cannabis Res; 2020 Oct; 2(1):38. PubMed ID: 33526136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis flower prices and transitions to legal sources after legalization in Canada, 2019-2020.
    Wadsworth E; Driezen P; Pacula RL; Hammond D
    Drug Alcohol Depend; 2022 Feb; 231():109262. PubMed ID: 34998249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis-related driving and passenger behaviours among high school students: a cross-sectional study using survey data.
    Carpino M; Langille D; Ilie G; Asbridge M
    CMAJ Open; 2020; 8(4):E754-E761. PubMed ID: 33234582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perceptions of the health risks of cannabis: estimates from national surveys in Canada and the United States, 2018-2019.
    Goodman S; Hammond D
    Health Educ Res; 2022 Mar; 37(2):61-78. PubMed ID: 35311986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.